News | RIVM

First patient with monkeypox in the Netherlands

This afternoon, a patient with monkeypox was confirmed in the Netherlands for the first time. RIVM researchers confirmed that the person has monkeypox with a PCR test.

Science Photo Library / ANP

From 1 June 2022, heel prick test also screens for muscle disease SMA, bringing number of screened diseases to 26

From 1 June 2022, the heel prick test for Dutch newborns will also screen for spinal muscular atrophy (SMA). SMA is a serious hereditary muscle condition. Detecting this disease at an early stage enables early treatment.

Tailor-made information will help immigrants make decisions on taking part in screening programmes

Immigrants are relatively less likely to take part in preventive screening programmes, such as cancer screening. This is partly due to the language barrier and a lack of knowledge, according to a doctoral thesis by Nora Hamdiui.

RIVM expands HPV vaccination programme: girls and boys protected from six types of cancer with one vaccine

Now not only girls, but also boys will have the opportunity to protect themselves from cancer caused by HPV.

Jongen en meisjes poseren op een kruk voor campagneposter HPV vaccin

Breast cancer screening resumes on Bonaire after COVID-19 hiatus

Women aged 50 to 75 years on Bonaire can participate in the breast cancer screening programme again as of Wednesday, May 26, 2021. This was temporarily halted in 2020 due to the COVID-19 pandemic.

Population screening programmes temporarily on hold

Due to the novel coronavirus (COVID-19) outbreak, the health care capacity in the Netherlands is expected to come under severe pressure in the coming period.

State Secretary Blokhuis: boys will also be vaccinated against HPV virus

The vaccine against the HPV human papillomavirus virus will also become available for boys.

Research: HPV vaccine is safe

RIVM research shows no causal link between the vaccine against cervical cancer (HPV) and long-term fatigue symptoms in girls.

Vaccination rate again drops slightly, HPV vaccination rate drops considerably

The vaccination rate for vaccines included in the National Immunisation Programme has dropped slightly by about 1 percent.

RIVM and Olive Foundation open trading to mark the European Cervical Cancer Prevention Week

January 20th, the Olive Foundation and RIVM opened AEX trading day in Amsterdam on the occasion of the 9th European Cervical Cancer Prevention Week.